I born on 7 April 1944 and live in Pisa, Italy. I am married and have three children born in 1972, 1977 and 1987. I achieved the Laurea (highest degree of the Italian University) in Biological Sciences at the University of Pisa in 1971. I achieved the PhD in Medical Sciences at Karoliska Institutet (Stockholm, Sweden) in 1983.
) Department of Translational Research and New Technologies in Medicine and Surgery University of Pisa Pisa Italy
Dr. Charles M. Beasley, Jr., M.D. and Board certified in General psychiatry, is the founder and president of Beasley Pharmaceutical and Biotechnology Consulting LLC. He worked in clinical development and drug safety for Eli Lilly (Indianapolis, USA) for 27 years, retiring as Distinguished Lilly Scholar in 2015. His work included late stage development with fluoxetine, olanzapine, atomoxitine, duloxetine, and tadalafil. Dr. Beasley has published over 95 peer-reviewed articles. He is an inventor of eight olanzapine patents, and he has memberships in AOA and ASCP. He is a Distinguished Life Fellow of the APA, a fellow of the ACPsych, the ACNP and the Faculty of Pharmaceutical Medicine of the Royal College of Physicians of the UK.
) Beasley Pharmaceutical and Biotechnology Consulting, LLC Indianapolis, IN USA
Giuseppe De Rosa graduated in 1997 in Pharmaceutical Chemistry and Technology at the University of Napoli Federico II. In 2001 he completed a Ph.D. in Pharmaceutical Technology with a dissertation with the title “Delivery of biotechnological drugs by biodegradable microspheres”, with research activity carried out in part at the University Paris-Sud of Chatenay-Malabry (France). From 1999 to 2002, he carried out research activity at the University Paris-Sud of Chatenay-Malabry (France). From 2002 Dr De Rosa was assistant professor at the Faculty of Pharmacy – University of Naples Federico II. From 2014, Dr De Rosa is associate professor at the Department of Pharmacy, University of Naples Federico II. In the same year, he received the national scientific qualification as full professor.
) Department of Pharmacy University Federico II of Naples Naples Italy
Prof. Shufeng Zhou, M.D., Ph.D., completed his clinical medical training in China in 1986 and obtained his Ph.D. in 2001 from the School of Medicine, the University of Auckland, New Zealand. Prof. Zhou is Dean of the College of Chemical Engineering at Huaqiao University, Xiamen, China. His major research interests are drug discovery and development, drug metabolism & medicinal chemistry, nanomaterials for drug design, and pharmacogenomics. He is one of the Highly Cited Researchers in 2014, 2015 and 2016 according to Thomson Reuters. Prof. Zhou has published more than 450 peer-reviewed papers in various pharmacology and medical journals. Moreover, he has published 17 books and book chapters, and more than 480 conference abstracts.
) College of Chemical Engineering Huaqiao University Xiamen China
Dr. Ian C. Chikanza is an experienced academic, is a consultant physician in rheumatology with an acute business acumen, has a demonstrated track record of charity service and is working in the medical practice industry. He is skilled in negotiation, petroleum and chemical industry, business planning, laboratory and clinical research and strategic planning. After graduating from the University of Zimbabwe with MB ChB, he worked with Dr. Laing and the government of Zimbabwe (funded by Save Children UK) to set up the first ever charitable Farm Worker Health Scheme in farms in Zimbabwe. In this venture, he was supported by his mother (who is a nutritionist and teacher).
) Department of Rheumatology The Royal London Hospital London UK
Upendra A. Argikar is a Senior Research Investigator at Novartis Institutes for Biomedical Research, Inc. in Cambridge, Massachusetts, USA. He received a Ph.D. in Medicinal Chemistry from University of Minnesota, USA. He has 15+ years of research experience in drug metabolism and pharmacokinetics. At Novartis he has been an active member of projects spanning many disease areas. Currently, he focuses on metabolite identification and structure elucidation of new chemical entities and clinical candidates. Upendra has continued to be interested in conjugative metabolism by uridine diphospho-glucuronosyl transferases, a topic on which he has co-authored research articles, reviews, and book chapters.
) Analytical Sciences and Imaging Novartis Institutes for BioMedical Research, Inc Cambridge, MA USA
Professor Jerzy Beltowski obtained a doctorate (Ph.D) in medicine from the Medical University, Lublin, Poland. Professor Beltowski is the full professor in the Department of Pathophysiology of the Medical University, Lublin, Poland. He published 140 full-length papers which have been cited more than 3000 times. His “h” index is now 27. He delivered lectures at about 30 international congresses, in most cases as the invited speaker. He has also been the reviewer of many grant applications including EU Horizon 2020 program.
) Department of Pathophysiology Medical University of Jaczewskiego Lublin Poland
Dr. Gentile is a recognized expert in the transglutaminase research area and has a strong background in the molecular biology and biochemical aspects of the transglutaminase (TG) enzymes expression, activity and function. His work has been focused to the tTG (TG2) characterization in normal and pathological cellular events (cell growth and differentiation, adhesion, apoptosis, neurodegeneration) by biochemical and molecular biology studies. Currently dr. Gentile is Researcher at the University of Campania “Luigi Vanvitelli”.
) Department of Precision Medicine CIRN University of Campania "Luigi Vanvitelli" Naples Italy
Mauro Magnani is full Professor of Biochemistry and Dean at the University of Urbino, Italy. Member of different Scientific Societies it is also serving as a President of The Italian Society of Biochemistry. With more than 500 papers published in international referred journal has more than 14,500 citations and an H index of 57. Actually is actively involved in the development of new drug delivery systems with special attention to the use of red blood cells and to the development of new human recombinant proteins (monoclonal antibodies and recombinant enzymes) for the treatment of rare diseases and rare tumors. Referee for several international governmental and private organizations has received many scientific recognitions and is listed as inventor in more than 14 patent families.
) Department of Biomolecular Sciences University of "Carlo Bo" Urbino Italy
Ryuichi Morishita, M.D., Ph.D., graduated Osaka University Medical School in 1987, and received Ph. D. from Osaka University in 1991. After postdoctoral Fellow at Stanford University School of Medicine, he served as an Assistant Professor, Department of Geriatric Medicine, Osaka University Medical School from 1994 to 1998. Then, from 1998 to 2003, he was Associate Professor, Division of Gene Therapy Science, Osaka University Medical School. Then, he became Professor & Chairman of Division of Clinical Gene Therapy, Graduate School of Medicine, Osaka University Medical School from 2003.
) Department of Clinical Gene Therapy Osaka University Suita Japan
Maurizio Renna (MSc in Medical Biotechnologies, PhD in Biochemistry, Pathology and Mechanisms of Drug Action) is a Research Associate at the Cambridge Institute for Medical Research, University of Cambridge.
During his PhD, he studied the regulation of gene expression and intracellular trafficking in response to ER stress. Currently, he is focused on the study of autophagy, a catabolic process responsible for the removal of long-lived proteins, damaged organelles and intracellular pathogens, whose alteration is associated to several human diseases. He aims at identifying novel mechanisms regulating this pathway and providing alternative approaches for the treatment of clinically relevant conditions.
) Department of Medical Genetics University of Cambridge UK
Dr Haladhar Dev Sarma holds Master’s degree in Veterinary Science and Doctorate degree in Basic Medical Sciences. Has extensive experience in pre-clinical studies and development of experimental animal models for radiation and cancer biology research. He and his co-workers developed a number of radiopharmaceutical products for cancer theranostics. Serving as reviewer for about twenty scientific journals and editorial board member for half of them. Has been recipient of several national and international awards for scientific excellence and has co-authored more than 200 research publications.
) Experimental Animal Facility & Radioisotope Laboratory Bhabha Atomic Research Centre Mumbai India
Lakshmi Sivasubramanian’s qualifications include B.Pharm, M.Pharm, PhD and PGDIPR. She is a Professor of Pharmaceutical Analysis and currently working as Vice Principal (Academics) at Sri Venkateswara College of Pharmacy, Chittoor, AP, India. She has more than 15 years of academic and research experience in the field of Pharmaceutical Analysis. She has published around 51 papers in various National and International Journals, which have collectively gained more than 350 citations. She has delivered many invited lectures on spectral interpretations. Her major research interest includes development of new analytical methods using UV, HPLC and HPTLC, chemometrics and cognitive science. She has obtained travel grants and research grants from DST and AICTE, Govt of India.
) Department of Pharm Analysis Sri Venkateswara College of Pharmacy Chitoor India
Dr. Milagros Méndez Ubach was born on May 10th, 1957 in Mexico. She completed her B.Sc. Biology, Universidad Nacional Autónoma de México (UNAM), Mexico, 1981. M.Sc. Biochemistry, Facultad de Química, Universidad Nacional Autónoma de México (UNAM), Mexico, 1986. Ph.D. Biomedical Research, Unidad Académica de los Ciclos Profesional y de Posgrado del Colegio de Ciencias y Humanidades (UACPyP-CCH), Universidad Nacional Autónoma de México (UNAM), Mexico, 1990. Postdoctoral Neurobiology, Centre de Neurochimie, INSERM U. 338, Strasbourg, France (1990-1991). Postdoctoral Neurobiology and Molecular Biology, Unité de Recherches en Imagerie Quantitative Appliquée aux Régulations Neuroendocriniennes, INSERM U. 339, Paris, France (1993-1995)
) Department of Neurochemistry National Institute of Psychiatry “Ramón de la Fuente Muñiz” Mexico City Mexico
Eugenio Barone, is Assitant Professor of Biochemistry at Sapienza University of Rome. His research work focuses on the role of the oxidative stress-induced proteins post-transaltional modifications in neurodegeneration and on the molecular mechanism(s) promoting brain insulin resistance. He unravelled the role of the biliverdin reductase-A protein along the progression of AD pathology making advances in understanding the properties of this unique protein either as antixidant or regulator of the insulin signalling cascade. Other research topics include (i) the role of dietary antioxidant in neurodegenerative disease, (ii) the design and synthesis of new drug delivery systems (iii) the caracterization of the molecular mechanism linking obesisty and neurodegeneration.
) Department of Biochemical Sciences “A. Rossi-Fanelli” Sapienza University of Rome Rome Italy
Professor Guglielmo Borgia was borne in Naples on May 19th,1949. He got a doctor’s degree on July 1973. He is specialist in Infectious Diseases, Hygiene, Internal Medicine. He is full professor of Infectious Diseases, Chief Physician of Infectious Diseases Unit and Chairman of residence Program of Infectious Diseases at University of Naples “Federico II”. He has carried out researches mainly on epidemiology, prevention, therapy, and ultrastructure of acute and chronic viral hepatitis. He is author of about
280 papers published in National and International Journals and reviewers for several scientific journals. He acted as referee for scientific projects of National Institute of Health (NIH- USA) and for Italian “Ministero della Università e Ricerca Scientifica” and “Ministero della Salute”.
) Infectious Diseases Unit University of Naples “Federico II” Naples Italy
Prof. Kexin Liu received his Ph.D. degree in Pharmacy from The University of Tokyo (Department of Pharmaceutics, Faculty of Pharmaceutical Sciences), Japan. He is currently Professor in the Department of Clinical Pharmacology, College of Pharmacy, at Dalian Medical University, China. The focus of his research lies in the following: Pharmacokinetics; Pharmacology; Transporter-mediated drug-drug interaction and MDR; ABC transporters; PEPTs, OATs and OATPs; and, Toxicology. Prof. Liu, as an author/co-author, has published more than 235 articles in various journals, having a significant number of total citations, i.e. over 2,985.
) Department of Clinical Pharmacology Dalian Medical University Dalian China
I was born on 05 Augusts 1973 in Shahrood, Iran. I got my PhD in the in Analytical Chemistry with a focus on herbal and medicinal plants in 2005. In the recent decades, I have been working on characterization, processing of medicinal plants and assessments of their biological activities. They may be considered as proper alternatives for chemical drugs with noxious side effects. At the present, I am an Associate Professor in the Chemistry Department of Islamic Azad University, Shahrood Branch, Shahrood, Iran. I'm also the Editor-in-Chief of an international journal, namely “Trends in Phytochemical Research (TPR)”
) Department of Chemistry Islamic Azad University Shahrood Iran
José Francisco Navarro, PhD, is Professor of Psychobiology at the University of Málaga, Spain. His area of interest is focused on experimental psychopharmacology. He has developed studies mainly in neuropsychopharmacology of aggression, sleep and drug addiction (GHB, MDMA, etc), with approximately 215 papers published in scientific journals.
) Departament of Psychobiology University of Málaga Málaga Spain
Dr. Resende holds a degree in Biological Sciences and Pharmacy, specialization in Clinical Analysis. He holds a PhD in Biochemistry, a postdoctoral degree in biophysics and another in physics in the application and production of nanomaterials for nanobiotechnology. Currently, he is President of the Brazilian Society of Cellular Signaling (SBSC). Also, Dr. Resende is founding President of the Nanocell Institute for Scientific Research and Science Dissemination http://www.institutonanocell.org.br/.
) Departamento de Bioquímica e Imunologia Universidade Federal de Minas Gerais Belo Horizonte Brazil
Dr. Federico Sesti is a Professor of Neuroscience and Cell Biology, at Robert Wood Johnson Medical School, Rutgers University. He received his Ph.D. degree in Physics from the University of Genova, Italy. He was a postdoctoral fellow in the laboratory of (Germany) and in the laboratory of Steve Goldstein at Yale University (USA). He joined the Robert Wood Johnson Medical School in 2001. His areas of studies are Biochemistry, Genetics and Molecular Biology Neuroscience Engineering Agricultural and Biological Sciences Medicine Materials Science Chemistry Chemical Engineering Immunology and Microbiology. He has contributed more than 40 publications, having citations around 3000.
) Neuroscience and Cell Biology Rutgers University Brunswick, NJ USA
Raffaella Sorrentino is Associate Professor of Pharmacology at the University of Naples. In 1994 she got the PhD in Pharmacology. She worked at the William Harvey Research Institute (London), headed by Prof. Sir John Vane (Nobel in Medicine). Received the “UPJOHN ACHIEVEMENT AWARD Excellence in Pharmacology” in 1992. Her scientific interest is related to the role of gaseous transmitters in physiological and pathological conditions such as cardiovascular and inflammatory process and more recently in urogenital tract. Her scientific production is validated by 84 full paper published on peer reviewed journals.
She is a Membership of “Società Italiana di Farmacologia”.
) Department of Pharmacy University of Naples "Federico II" Naples Italy
Dimitri P. Mikhailidis graduated from the University of London (BSc, MSc, MB,BS and MD) and is the former Academic Head, Department of Clinical Biochemistry, Royal Free Hospital campus, University College London Medical School, University College London (UCL), UK. He continues with academic duties at UCL. He also is a Visiting Professor, Univ. of Belgrade, Serbia, and two universities in Saudi Arabia (King Saud Univ., Riyadh, King Khalid Univ., Abha). His clinical interest is vascular disease prevention, and his research interests are dyslipidaemias and thrombosis. He is a former Wellcome Trust fellow and has supervised 15 doctoral students (University of London). He has 1206 entries on PubMed and 24,960 citations listed in the ISI index, Core Collection (H-factor = 67). He is editor-in-chief of several journals.
) Department of Clinical Biochemistry University College London (UCL) London UK
Dr. Purnima Ashok is presently working as a Professor and Head at KLE University’s College of Pharmacy. She has obtained Ph.D. and her skills and expertise are in Pharmacology, Toxicology and Pharmaceutics Medicine Biochemistry, Genetics and Molecular Biology Agricultural and Biological Sciences Chemistry Chemical Engineering Materials Science. She has contributed around 68 publications. She has obtained around 605 citations in different publications.
) Department of Pharmacology /Pharmacy Practice KLE University’s College of Pharmacy Bangalore India
Dr. Sally Abdul Wanees Amin El Awdan obtained her Ph.D. degree (2011) in Pharmacy (Pharmacology and Toxicology) from Cairo University, Egypt. Since 2016, she is Assistant Professor in the Department of Pharmacology, National Research Centre, Dokki, Egypt. She has been the Principal Investigator of 2 projects; one from 2013 to 2016 and the second from 2016 to 2019. Dr. El Awdan, as an author/co-author, has published more than 30 articles in various journals, having total number of citations of around 100. Some awards that she has been bestowed with are as follows: National Research Centre Prize to Pioneers (Prof. Dr. Usama Al Shabrawy Prize) in 2016, award of ISI publishing in the NRC in 2015, etc.
) Pharmacology Department National Research Centre Giza Egypt
Dr. Subrahmanya K. Bhat obtained his Ph.D. degree (2005) in Medicinal Chemistry from the Department of Chemistry, Mangalore University, Mangalore, India. Since Nov 2010, Dr. Bhat is Associate Professor in the Department of Chemistry (Manipal Institute Of Technology) at Manipal University, Manipal, India. He has experience in organic synthesis, Heterocyclic chemistry, Pharmacology, Methods in organic synthesis, bisphenols and related monomers and tailoring of polymer properties. In addition, he has experience in a range of analytical data interpretation, i.e. UV-Visible, FT-IR, NMR and LC-MS. Dr. Bhat, as an author/co-author, has published more than 25 articles in various journals, having over 655 total citations.
) Department of Chemistry Manipal Institute of Technology Manipal India
Dr. Lauro Figueroa V completed Masters in Pharmacology from Instituto Politecnico Nacional, México, 1998 and PhD (Pharmacology) from University Autónomous Metropolitan, Mexico, 2001. Currently, he is Professor Research in University Autonomous of Campeche (Faculty of Chemical-Biological Sciences; 2005-2018). Before that he has worked in University Juarez Autonomous of Tabasco, Faculty Medicine as a Professor Research. He is the author of 114 papers in several journals as Steroids, African J. Pharmacy Pharmacol, Biomedical Papers, Chemical J., Organic let., and others. Presently, he is working on a project “Design and biological activity of new drugs to ischemia-reperfusion injury in heart”.
) Faculty of Chemical-Biological Sciences University Autonomous of Campeche Campeche Mexico